Institutions / Geode Capital Management, LLC / Activity
Activity — Geode Capital Management, LLC
3,417 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q1 2026 as of | Add | ATRA Atara Biotherapeutics, Inc. Common Stock | $17.8K | +4K +6.04% | 66,146 <0.01% of portfolio | low |
| Q1 2026 as of | Add | 676206105 Common stock | $17.9K | +9K +45.15% | 28,952 <0.01% of portfolio | low |
| Q1 2026 as of | Add | 01861F102 Common stock | $18.2K | +3K +11.23% | 27,515 <0.01% of portfolio | low |
| Q1 2026 as of | Add | 00091F304 Common stock | $18.2K | +19K +9.29% | 221,169 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Pixelworks, Inc Common stock | $18.3K | +3K +5.75% | 62,157 <0.01% of portfolio | low |
| Q1 2026 as of | Add | 92859G608 Common stock | $18.5K | +5K +2.24% | 249,016 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Exagen Inc. Common stock | $18.6K | +6K +3.58% | 178,857 <0.01% of portfolio | low |
| Q1 2026 as of | Add | HIT Health In Tech, Inc. Common Stock | $18.6K | +13K +7.52% | 183,325 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Bluerock Homes Trust, Inc. Common stock | $18.8K | +2K +4.27% | 40,422 <0.01% of portfolio | low |
| Q1 2026 as of | Add | IBN Icici Bank Ltd ADR | $18.9K | +728 +4.50% | 16,898 <0.01% of portfolio | low |
| Q1 2026 as of | Add | 573863107 Common stock | $19.0K | +25K +189.82% | 38,908 <0.01% of portfolio | low |
| Q1 2026 as of | Add | 126601103 Common stock | $19.1K | +5K +6.88% | 71,437 <0.01% of portfolio | low |
| Q1 2026 as of | Add | 762093102 Common stock | $19.1K | +1K +1.34% | 93,609 <0.01% of portfolio | low |
| Q1 2026 as of | Add | ALZN Alzamend Neuro, Inc. Common Stock | $19.3K | +18K +66.07% | 45,680 <0.01% of portfolio | low |
| Q1 2026 as of | Add | MIRA Mira Pharmaceuticals, Inc. Common Stock | $19.3K | +18K +6.60% | 290,890 <0.01% of portfolio | low |
| Q1 2026 as of | Add | MNOV Medicinova Inc Common Stock | $19.5K | +14K +2.69% | 543,843 <0.01% of portfolio | low |
| Q1 2026 as of | Add | CVM Cel Sci Corp Common Stock | $19.7K | +6K +7.74% | 85,311 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Sobr Safe, Inc. Common stock | $20.0K | +40K +375.45% | 50,450 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Y2001C101 Common stock | $20.0K | +1K +1.23% | 106,689 <0.01% of portfolio | low |
| Q1 2026 as of | Add | 307675108 Common stock | $20.0K | +16K +7.11% | 237,514 <0.01% of portfolio | low |
| Q1 2026 as of | Add | 02115D208 Common stock | $20.0K | +11K +2.35% | 473,195 <0.01% of portfolio | low |
| Q1 2026 as of | Add | KVHI Kvh Industries Inc \De Common Stock | $20.1K | +2K +1.40% | 162,345 <0.01% of portfolio | low |
| Q1 2026 as of | Add | 22529Y408 Common stock | $20.2K | +10K +34.51% | 38,290 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Lantern Pharma Inc. Common stock | $20.4K | +15K +15.41% | 111,646 <0.01% of portfolio | low |
| Q1 2026 as of | Add | 68622E104 Common stock | $20.5K | +40K +1.60% | 2,552,042 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Lixte Biotechnology Holdings, Inc. Common stock | $20.5K | +7K +12.82% | 58,852 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Inseego Corp Common stock | $20.6K | +2K +0.66% | 282,502 <0.01% of portfolio | low |
| Q1 2026 as of | Add | 05344R302 Common stock | $20.7K | +39K +170.53% | 61,949 <0.01% of portfolio | low |
| Q1 2026 as of | Add | XTNT Xtant Medical Holdings, Inc. Common Stock | $20.8K | +37K +7.57% | 529,214 <0.01% of portfolio | low |
| Q1 2026 as of | Add | 29350E203 Common stock | $20.9K | +51K +39.10% | 182,237 <0.01% of portfolio | low |
| Q1 2026 as of | Add | NYC American Strategic Investment Co. Common Stock | $20.9K | +2K +14.41% | 19,452 <0.01% of portfolio | low |
| Q1 2026 as of | Add | ZEO Zeo Energy Corp. Common Stock | $20.9K | +36K +39.09% | 129,692 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Leslie's Inc Common stock | $21.0K | +19K +21.82% | 104,579 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Atlanta Braves Holdings, Inc. Common stock | $21.0K | +446 +0.19% | 232,255 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Xenetic Biosciences, Inc. Common stock | $21.1K | +8K +57.87% | 21,441 <0.01% of portfolio | low |
| Q1 2026 as of | Add | SOAR Volato Group, Inc. Common Stock | $21.3K | +93K +193.37% | 140,436 <0.01% of portfolio | low |
| Q1 2026 as of | Add | 48301N104 Common stock | $21.5K | +38K +52.80% | 111,290 <0.01% of portfolio | low |
| Q1 2026 as of | Add | 949503106 Common stock | $21.5K | +223K +45.83% | 710,766 <0.01% of portfolio | low |
| Q1 2026 as of | Add | 825693401 Common stock | $21.6K | +32K +219.97% | 46,217 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Forte Biosciences, Inc. Common stock | $21.6K | +833 +0.67% | 125,442 <0.01% of portfolio | low |
| Q1 2026 as of | Add | 66373M408 Common stock | $21.9K | +153K +152.75% | 252,799 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Gossamer Bio, Inc. Common stock | $22.0K | +67K +1.37% | 4,939,691 <0.01% of portfolio | low |
| Q1 2026 as of | Add | DXLG Destination Xl Group, Inc. Common Stock | $22.1K | +43K +7.97% | 587,761 <0.01% of portfolio | low |
| Q1 2026 as of | Add | 37149D204 Common stock | $22.2K | +86K +213.63% | 126,888 <0.01% of portfolio | low |
| Q1 2026 as of | Add | RAIN Rain Enhancement Technologies Holdco, Inc. Common Stock | $22.5K | +9K +40.84% | 30,538 <0.01% of portfolio | low |
| Q1 2026 as of | Add | 91060H108 Common stock | $22.7K | +20K +12.86% | 172,058 <0.01% of portfolio | low |
| Q1 2026 as of | Add | CPIX Cumberland Pharmaceuticals Inc. Common Stock | $22.8K | +7K +6.54% | 114,293 <0.01% of portfolio | low |
| Q1 2026 as of | Add | 45765Y204 Common stock | $22.9K | +6K +40.85% | 19,997 <0.01% of portfolio | low |
| Q1 2026 as of | Add | BWEN Broadwind, Inc. Common Stock | $23.0K | +11K +4.62% | 251,025 <0.01% of portfolio | low |
| Q1 2026 as of | Add | SHFS SHF Holdings, Inc. Common Stock | $23.1K | +28K +219.64% | 40,438 <0.01% of portfolio | low |